These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38528621)

  • 1. Haematoidin in chronic myelomonocytic leukaemia during irregular treatment with hydroxycarbamide.
    Zhang X; Tao C; Long F
    Br J Haematol; 2024 May; 204(5):1569-1570. PubMed ID: 38528621
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia.
    Otrock ZK; Taher AT; Mahfouz RA; Makarem JA; Shamseddine AI
    Am J Hematol; 2006 Mar; 81(3):220-1. PubMed ID: 16493602
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID-19 pneumonia.
    Chopra J; Hiew HJ; Cumpstey A; Cagampang F; Jenner MW; Dushianthan A
    Br J Haematol; 2020 Aug; 190(4):e195-e198. PubMed ID: 32593202
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy Case.
    Imai H; Matsumura N; Yamazaki Y; Kanayama Y; Masuda T; Kuwako T; Kamide Y; Tomizawa T; Matsumoto S; Mitsui T; Kaira K; Ono A; Koga Y; Shibusawa N; Sunaga N; Hisada T; Yokoo H; Yamada M
    Intern Med; 2015; 54(24):3171-6. PubMed ID: 26666606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
    Pleyer L; Leisch M; Kourakli A; Padron E; Maciejewski JP; Xicoy Cirici B; Kaivers J; Ungerstedt J; Heibl S; Patiou P; Hunter AM; Mora E; Geissler K; Dimou M; Jimenez Lorenzo MJ; Melchardt T; Egle A; Viniou AN; Patel BJ; Arnan M; Valent P; Roubakis C; Bernal Del Castillo T; Galanopoulos A; Calabuig Muñoz M; Bonadies N; Medina de Almeida A; Cermak J; Jerez A; Montoro MJ; Cortés A; Avendaño Pita A; Lopez Andrade B; Hellstroem-Lindberg E; Germing U; Sekeres MA; List AF; Symeonidis A; Sanz GF; Larcher-Senn J; Greil R
    Lancet Haematol; 2021 Feb; 8(2):e135-e148. PubMed ID: 33513373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic Myelomonocytic Leukemia with Myelofibrosis Resulting in Sudden Massive Pleural Effusion during Cytoreductive Therapy with Hydroxycarbamide].
    Sunami Y; Gotoh A; Watanabe N; Edahiro Y; Hamano Y; Harada H; Komatsu N
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1223-1226. PubMed ID: 27760943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrotic Lung Toxicity Induced by Hydroxycarbamide.
    Bargagli E; Palazzi M; Perri F; Torricelli E; Rosi E; Bindi A; Pistolesi M; Voltolini L
    In Vivo; 2017; 31(6):1221-1223. PubMed ID: 29102950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myelomonocytic leukaemia associated with acquired haemophilia A: case report and literature review.
    Liang Y; Lu RN; Wang R; Zhang JF; Su W; Li JY; Zhang SJ; Lu H
    Haemophilia; 2015 Jul; 21(4):e341-3. PubMed ID: 25982484
    [No Abstract]   [Full Text] [Related]  

  • 9. Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
    Huemer F; Weiss L; Faber V; Neureiter D; Egle A; Geissler K; Voskova D; Zebisch A; Burgstaller S; Pichler A; Stauder R; Sperr W; Lang A; Pfeilstöcker M; Machherndl-Spandl S; Stampfl M; Greil R; Pleyer L
    Wien Klin Wochenschr; 2018 Feb; 130(3-4):115-125. PubMed ID: 29383443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group.
    Wattel E; Guerci A; Hecquet B; Economopoulos T; Copplestone A; Mahé B; Couteaux ME; Resegotti L; Voglova V; Foussard C; Pegourié B; Michaux JL; Deconinck E; Stoppa AM; Mufti G; Oscier D; Fenaux P
    Blood; 1996 Oct; 88(7):2480-7. PubMed ID: 8839839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.
    Hilmi M; Bally C; Burns R; Lorillon G; Bergeron A; Fenaux P; Ades L
    Ann Hematol; 2018 Mar; 97(3):541-542. PubMed ID: 29170809
    [No Abstract]   [Full Text] [Related]  

  • 12. Pleural effusion heralds acute leukemic transformation of chronic myelomonocytic leukemia.
    Huang CT; Kuo PH; Yao M; Tsai YJ; Yang PC
    South Med J; 2008 Dec; 101(12):1279-80. PubMed ID: 19005440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic myelomonocytic leukemia with pleural effusion as the first clinical sign].
    Yamazaki E; Kanai M; Sakai R; Sakamoto H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Mar; 46(3):217-9. PubMed ID: 16447718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.
    Itzykson R; Santini V; Thepot S; Ades L; Chaffaut C; Giagounidis A; Morabito M; Droin N; Lübbert M; Sapena R; Nimubona S; Goasguen J; Wattel E; Zini G; Torregrosa Diaz JM; Germing U; Pelizzari AM; Park S; Jaekel N; Metzgeroth G; Onida F; Navarro R; Patriarca A; Stamatoullas A; Götze K; Puttrich M; Mossuto S; Solary E; Gloaguen S; Chevret S; Chermat F; Platzbecker U; Fenaux P
    J Clin Oncol; 2023 Apr; 41(10):1888-1897. PubMed ID: 36455187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous infiltratiton by chronic myelononocytic leukemia: presentation of three cases].
    Prada Garcia C; Sanchez Sambucety P; Rodriguez Prieto MÁ
    Dermatol Online J; 2013 Nov; 19(11):20408. PubMed ID: 24314783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options and survival in real life during the past three decades in patients with chronic myelomonocytic leukemia.
    Reiser J; Geissler K
    Wien Med Wochenschr; 2023 Feb; 173(1-2):34-40. PubMed ID: 36282401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension in a child with juvenile myelomonocytic leukemia secondary to pulmonary leukemic cell infiltration.
    Alioglu B; Demirhan B; Ozyurek E; Varan B; Erbay A; Ozbek N
    Pediatr Hematol Oncol; 2006 Dec; 23(8):667-75. PubMed ID: 17065143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia.
    Mellibovsky L; Díez A; Aubia J; Nogues X; Pérez-Vila E; Serrano S; Recker RR
    Br J Haematol; 1993 Dec; 85(4):811-2. PubMed ID: 7918050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia.
    Drummond MW; Pocock C; Boissinot M; Mills J; Brown J; Cauchy P; Cross NC; Hartley S; Kell J; Szubert A; Cockerill PN; Bowen DT
    Leukemia; 2014 Jul; 28(7):1570-2. PubMed ID: 24569776
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to erythropoietin in chronic myelomonocytic leukaemia.
    Kerridge I; Spencer A; Azzi A; Seldon M
    Intern Med J; 2001 Aug; 31(6):371-2. PubMed ID: 11529594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.